Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Emma Clark.
Newcastle Authors
Title
Year
Full text
Dr Nicola Wyatt
Dr Hannah Watson
Dr Dean Allerton
Michelle Bardgett
Dr Emma Clark
et al.
Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: Protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
2024
Sean Carrie
Tony Fouweather
Tara Homer
James O'Hara
Alison Bray
et al.
Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT
2024
Sean Carrie
James O'Hara
Tony Fouweather
Tara Homer
Dr Nikki Rousseau
et al.
Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial
2023
Dr Ge Yu
Stephen Rice
Professor Rakesh Heer
Dr Emma Clark
Professor Luke Vale
et al.
Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial
2023
Dr Emma Clark
Dr Holly Fisher
Jenn Walker
Ruth Wood
Professor Helen Hancock
et al.
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial
2023
Professor Luke Vale
Dr Jing Shen
Dr Emma Clark
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: A study protocol for a randomised trial of clinical and cost-effectiveness
2019
Dr Emma Clark
Dr Miranda Patterson
Shriya Sharma
Dr Holly Fisher
Denise Howel
et al.
Prostate cancer androgen receptor splice variant 7 biomarker study - A multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol
2019
James Grey
Dr Dominic Jones
Laura Wilson
Dr Sirintra Nakjang
Jake Clayton
et al.
Differential regulation of the androgen receptor by protein phosphatase regulatory subunits
2018
Dr Emma Clark
Dr Richard Temperley
Amy Barnard
Professor Craig Robson
p68/DdX5 Supports β-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer
2013
Dr Prabhakar Rajan
Caroline Dalgliesh
Dr Kaveh Emami
Dr Emma Clark
Professor Craig Robson
et al.
Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies
2009
Dr Emma Clark
Professor David Elliott
Professor Craig Robson
Coupling transcription to RNA processing via the p68 DEAD box RNA helicase androgen receptor co-activator in prostate cancer
2008
Dr Emma Clark
Dr Anne Coulson
Caroline Dalgliesh
Dr Prabhakar Rajan
Professor Rakesh Heer
et al.
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer
2008
Catriona Manville
Dr Emma Clark
Dr Kay Padget
james Harvey
Dr Nick Morris
et al.
Bioinformatic analysis of topoisomerase II binding sites
2007
Dr Emma Clark
Topoisomerase IIa human genomic binding sites
2006
Dr Emma Clark
Thyroid hormone action in the placenta
2005
Dr Emma Clark
Dr Judith Bulmer
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies
2003